A carregar...
Hepatitis B Virus Reactivation in Cancer Patients Treated With Immune Checkpoint Inhibitors
There have been unique adverse events reported with targeted blockade of programmed death-1 (PD-1), programmed death-ligand-1 (PD-L1), and cytotoxic T-lymphocyte-associated protein-4 (CTLA4), including immune mediated toxicities. Recently, there have been reports of hepatitis B reactivation (HBVr) o...
Na minha lista:
| Publicado no: | J Immunother |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7946380/ https://ncbi.nlm.nih.gov/pubmed/33480637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000358 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|